Skip to main content
Richard Berman, MD, Anesthesiology, Philadelphia, PA

RichardA.BermanMD

Anesthesiology Philadelphia, PA

Critical Care Medicine

Assistant Professor, Anesthesiology, Jefferson Medical College-Thos Jefferson Univ

Dr. Berman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Berman's full profile

Already have an account?

  • Office

    111 S 11th St
    Ste 8490
    Philadelphia, PA 19107
    Phone+1 215-955-6161
    Fax+1 215-923-5507

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1976 - 1978
  • Duke University Hospital
    Duke University HospitalInternship, Internal Medicine, 1970 - 1971
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1970

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1978 - Present
  • PA State Medical License
    PA State Medical License 1985 - 2022
  • DC State Medical License
    DC State Medical License 1999 - 2002
  • TX State Medical License
    TX State Medical License 1977 - 1998
  • NY State Medical License
    NY State Medical License 1979 - 1994
  • SC State Medical License
    SC State Medical License 1974 - 1980
  • American Board of Anesthesiology Anesthesiology
  • American Board of Anesthesiology Critical Care Medicine
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013

Press Mentions

  • Penn Medicine Developed CAR T Cell Therapy Wins Third FDA Approval
    Penn Medicine Developed CAR T Cell Therapy Wins Third FDA ApprovalMay 28th, 2022